Treatment of Neuroendocrine Tumor Liver Metastases

by Lewis, Mark A., Hobday, Timothy J.
Published 2012

REGIONAL DIFFERENCES IN BREAST CANCER BIOMARKERS IN AMERICAN INDIAN AND ALASKA NATIVE WOMEN

by Kaur, Judith S, Vierkant, Robert A., Hobday, Timothy, Visscher, Daniel
Published 2014

Pilot Study Characterizing the Hematology-Oncology Fellow Job Search Process: Tools Used and Identification of Potential New Resources

by Marshall, Ariela L., Halfdanarson, Thorvardur R., Alkhateeb, Hassan, Hobday, Timothy
Published in J Cancer Educ (2021)

Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy

by Walia, Tamana, Quevedo, J Fernando, Hobday, Timothy J, Croghan, Gary, Jatoi, Aminah
Published 2008

Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights

by Starr, Jason S, Sonbol, Mohamad Bassam, Hobday, Timothy J, Sharma, Akash, Kendi, Ayse Tuba, Halfdanarson, Thorvardur R
Published in Onco Targets Ther (2020)

Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors

by Zhu, Mojun, Bassam Sonbol, Mohamad, Halfdanarson, Thorvardur, Hobday, Timothy, Ahn, Daniel, Ma, Wen Wee, Bekaii‐Saab, Tanios
Published in Oncologist (2020)

Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study

by Castellano, Daniel, Bajetta, Emilio, Panneerselvam, Ashok, Saletan, Stephen, Kocha, Walter, O'Dorisio, Thomas, Anthony, Lowell B., Hobday, Timothy
Published 2013

Dose Modification for Safe Treatment of a Compound Complex Heterozygous DPYD Variant Carrier With Fluorouracil

by Shrestha, Shikshya, Tapper, Erin E., Trogstad-Isaacson, Colbren (Scout), Hobday, Timothy J., Offer, Steven M., Diasio, Robert B.
Published in JCO Precis Oncol (2018)

N0436 (Alliance): A phase II trial of irinotecan plus cetuximab in patients with metastatic breast cancer previously exposed to anthracycline and/or taxane-containing therapy

by Crozier, Jennifer A., Advani, Pooja P., LaPlant, Betsy, Hobday, Timothy, Jaslowski, Anthony J., Moreno-Aspitia, Alvaro, Perez, Edith A.
Published in Clin Breast Cancer (2015)

Efficacy of Second-Line Chemotherapy in Extrapulmonary Neuroendocrine Carcinoma

by McGarrah, Patrick W., Leventakos, Konstantinos, Hobday, Timothy J., Molina, Julian R., Finnes, Heidi D., Westin, Gustavo F., Halfdanarson, Thorvardur R.
Published in Pancreas (2020)

Risk Factors for Pancreatic Neuroendocrine Tumors (PNETs): A Clinic-Based Case-Control study

by Halfdanarson, Thorvardur R., Bamlet, William R., McWilliams, Robert R, Hobday, Timothy J., Burch, Patrick A., Rabe, Kari G., Petersen, Gloria M.
Published in Pancreas (2014)

A randomized phase II trial evaluating two non-pharmacologic interventions in cancer survivors for the treatment of sleep-wake disturbances: NCCTG N07C4 (Alliance)

by Barton, Debra L, Atherton, Pamela J, Satele, Daniel V, Qin, Rui, Dakhil, Shaker, Pipe, Teri, Hobday, Timothy, Fee-Schroeder, Kelli, Loprinzi, Charles L.
Published in Support Care Cancer (2020)

Impact of Prior Chemotherapy Use on the Efficacy of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-3 Trial

by Lombard-Bohas, Catherine, Yao, James C., Hobday, Timothy, Van Cutsem, Eric, Wolin, Edward M., Panneerselvam, Ashok, Stergiopoulos, Sotirios, Shah, Manisha H., Capdevila, Jaume, Pommier, Rodney
Published in Pancreas (2015)

Long-Term Survivors of Metastatic Colorectal Cancer Treated with Systemic Chemotherapy Alone: A North Central Cancer Treatment Group Review of 3811 Patients, N0144

by Dy, Grace K., Hobday, Timothy J., Nelson, Garth, Windschitl, Harold E., O’Connell, Michael J., Alberts, Steven R., Goldberg, Richard M., Nikcevich, Daniel A., Sargent, Daniel J.
Published 2009

Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors

by Hobday, Timothy J., Qin, Rui, Reidy-Lagunes, Diane, Moore, Malcolm J., Strosberg, Jonathan, Kaubisch, Andreas, Shah, Manisha, Kindler, Hedy Lee, Lenz, Heinz-Josef, Chen, Helen, Erlichman, Charles
Published in J Clin Oncol (2015)

Treatment Outcomes of Well‐Differentiated High‐Grade Neuroendocrine Tumors

by Liu, Alex J., Ueberroth, Benjamin E., McGarrah, Patrick W., Buckner Petty, Skye A., Kendi, Ayse Tuba, Starr, Jason, Hobday, Timothy J., Halfdanarson, Thorvardur R., Sonbol, Mohamad Bassam
Published in Oncologist (2021)

Breast Medical Oncologists' Use of Standard Prognostic Factors to Predict a 21-Gene Recurrence Score

by Kamal, Arif H., Loprinzi, Charles L., Reynolds, Carol, Dueck, Amylou C., Geiger, Xochiquetzal J., Ingle, James N., Carlson, Robert W., Hobday, Timothy J., Winer, Eric P., Goetz, Matthew P.
Published 2011

Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors (pNET): Final Overall Survival (OS) Results of the RADIANT-3 Study

by Pommier, Rodney, Pavel, Marianne, Lombard-Bohas, Catherine, Van Cutsem, Eric, Lam, Du, Kunz, Tiffany, Brandt, Ulrike, Capdevila, Jaume, De Vries, Elisabeth G.E., Tomassetti, Paola, Hobday, Timothy, Yao, James C.
Published in Gastrointest Cancer Res (2014)

North Central Cancer Treatment Group (NCCTG) N0537: Phase II Trial of VEGF-Trap in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and/or a Taxane

by Sideras, Kostandinos, Dueck, Amylou C., Hobday, Timothy J., Rowland, Kendrith M., Allred, Jacob B., Northfelt, Donald W., Lingle, Wilma L., Behrens, Robert J., Fitch, Tom R., Nikcevich, Daniel A., Perez, Edith A.
Published 2012

NCCTG N0543 (Alliance): A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma

by McWilliams, Robert R., Foster, Nathan R., Mahoney, Michelle R., Smyrk, Thomas C., Murray, Joseph A., Ames, Matthew M., Horvath, Elise, Schneider, Daniel, Hobday, Timothy J., Jatoi, Aminah, Meyers, Jeffrey P., Goetz, Matthew P.
Published in Cancer (2017)